Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

The incidence of malignant pleural mesothelioma (MPM) in elderly patients is increasing. In this study, pooled data from two phase II trials of pemetrexed and carboplatin (PC) as first-line therapy were retrospectively analysed for comparisons between age groups. Patients received pemetrexed 500 mg ...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceresoli, G L, Castagneto, B, Zucali, P A, Favaretto, A, Mencoboni, M, Grossi, F, Cortinovis, D, Conte, G Del, Ceribelli, A, Bearz, A, Salamina, S, De Vincenzo, F, Cappuzzo, F, Marangolo, M, Torri, V, Santoro, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453025/
https://www.ncbi.nlm.nih.gov/pubmed/18542071
http://dx.doi.org/10.1038/sj.bjc.6604442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453025/
https://www.ncbi.nlm.nih.gov/pubmed/18542071
http://dx.doi.org/10.1038/sj.bjc.6604442

Ejemplares similares